IHS Chemical Week

People & Business :: M&A

Grovepoint acquires majority stake in biotech firm Algatechnologies

2:58 AM MST | February 19, 2013 | Natasha Alperowicz

Grovepoint (London), a private investment company, says it has acquired a majority stake in biotech company Algatechnologies (Hevel Eilot, Israel), a rapidly growing firm specializing in the commercial cultivation of microalgae and a leading manufacturer of natural astaxanthin AstaPure.   Astaxanthin is a natural antioxidant with proven health benefits in several health conditions related to joint and muscle function, skin-care health, and cardiovascular health. The product is already well established in Japanese health food and increased recognition of its...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa